Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials.
Saved in:
| Title: | Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials. |
|---|---|
| Authors: | Zhang H; Precision Medicine, R&D, GSK, Waltham, Massachusetts., Rutkowska A; Cellzome, a GSK Company, R&D, GSK, Heidelberg, Germany., González-Martín A; Medical Oncology Department, Clínica Universidad de Navarra, Madrid, Spain.; Center for Applied Medical Research (CIMA), Pamplona, Spain.; Grupo Español de Investigación en Cáncer de Ovario (GEICO), Madrid, Spain., Mirza MR; Nordic Society of Gynaecological Oncology (NSGO) and Department of Oncology Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark., Monk BJ; Florida Cancer Specialists and Research Institute, West Palm Beach, Florida., Vergote I; Gynecologic Oncology, Katholieke Universiteit Leuven, Leuven, Belgium., Pothuri B; Department of Obstetrics and Gynecology, NYU School of Medicine, New York City, New York., Graybill WAS; Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, South Carolina., Goessel C; Clinical Development, Oncology, GSK, Waltham, Massachusetts., Barbash O; Precision Medicine, GSK, Collegeville, Pennsylvania, Philadelphia., Bergamini G; Cellzome, a GSK Company, R&D, GSK, Heidelberg, Germany., Feng B; Precision Medicine, R&D, GSK, Waltham, Massachusetts. |
| Source: | Cancer research communications [Cancer Res Commun] 2025 Jan 01; Vol. 5 (1), pp. 178-186. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39636225 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhang+H%22">Zhang H</searchLink>; Precision Medicine, R&D, GSK, Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Rutkowska+A%22">Rutkowska A</searchLink>; Cellzome, a GSK Company, R&D, GSK, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22González-Martín+A%22">González-Martín A</searchLink>; Medical Oncology Department, Clínica Universidad de Navarra, Madrid, Spain.; Center for Applied Medical Research (CIMA), Pamplona, Spain.; Grupo Español de Investigación en Cáncer de Ovario (GEICO), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Mirza+MR%22">Mirza MR</searchLink>; Nordic Society of Gynaecological Oncology (NSGO) and Department of Oncology Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Monk+BJ%22">Monk BJ</searchLink>; Florida Cancer Specialists and Research Institute, West Palm Beach, Florida.<br /><searchLink fieldCode="AU" term="%22Vergote+I%22">Vergote I</searchLink>; Gynecologic Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Pothuri+B%22">Pothuri B</searchLink>; Department of Obstetrics and Gynecology, NYU School of Medicine, New York City, New York.<br /><searchLink fieldCode="AU" term="%22Graybill+WAS%22">Graybill WAS</searchLink>; Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, South Carolina.<br /><searchLink fieldCode="AU" term="%22Goessel+C%22">Goessel C</searchLink>; Clinical Development, Oncology, GSK, Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Barbash+O%22">Barbash O</searchLink>; Precision Medicine, GSK, Collegeville, Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Bergamini+G%22">Bergamini G</searchLink>; Cellzome, a GSK Company, R&D, GSK, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Feng+B%22">Feng B</searchLink>; Precision Medicine, R&D, GSK, Waltham, Massachusetts. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918281580506676%22">Cancer research communications</searchLink> [Cancer Res Commun] 2025 Jan 01; Vol. 5 (1), pp. 178-186. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918281580506676 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2767-9764 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227679764%22">27679764 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39636225 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/2767-9764.CRC-24-0191 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 178 Titles: – TitleFull: Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhang H – PersonEntity: Name: NameFull: Rutkowska A – PersonEntity: Name: NameFull: González-Martín A – PersonEntity: Name: NameFull: Mirza MR – PersonEntity: Name: NameFull: Monk BJ – PersonEntity: Name: NameFull: Vergote I – PersonEntity: Name: NameFull: Pothuri B – PersonEntity: Name: NameFull: Graybill WAS – PersonEntity: Name: NameFull: Goessel C – PersonEntity: Name: NameFull: Barbash O – PersonEntity: Name: NameFull: Bergamini G – PersonEntity: Name: NameFull: Feng B IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2025 Jan 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2767-9764 Numbering: – Type: volume Value: 5 – Type: issue Value: 1 Titles: – TitleFull: Cancer research communications Type: main |
| ResultId | 1 |